Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
IO Biotech, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Quarterly results
08/07/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Form of Warrant",
"Securities Purchase Agreement, by and among the Company and the Purchasers",
"Registration Rights Agreement, by and among the Company and the Purchasers",
"IO Biotech, Inc. Announces $75 Million Private Placement Financing • Offering includes participation from both new and existing healthcare-dedicated investors. • Proceeds extend the company's cash runway into the fourth quarter of 2025 NEW YORK, August 7, 2023 - IO Biotech, Inc. , a clinical biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced that it has entered into a definitive securities purchase agreement for a private placement that is expected to result in gross proceeds of approximately $75 million, before deducting offering expenses. The private placement includes participation from new and existing investors, including Lundbeckfonden BioCapital; Kurma Growth Opportunities Fund; Vivo Capital; Armisti...",
"Corporate Presentation"
07/18/2023 8-K Quarterly results
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/11/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces 2023 First-Quarter Results"
04/20/2023 8-K Quarterly results
03/14/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces 2022 Fourth-Quarter and Year-End Results"
03/14/2023 8-K Investor presentation
Docs: "IO Biotech, Inc., Investor Deck",
"IO Biotech, Inc., Investor Deck"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "IO Biotech, Inc., Investor Deck, released on January 9, 2023",
"IO Biotech Provides Business Update"
11/09/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces Third Quarter Results for 2022"
10/13/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces Appointment of New Chief Financial Officer"
08/11/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces Second Quarter Results for 2022"
05/26/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/16/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"IO Biotech Announces First Quarter Results for 2022"
05/13/2022 8-K Quarterly results
04/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/31/2022 8-K Quarterly results
03/16/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
12/17/2021 8-K Quarterly results
12/06/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy